Omada Health, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Omada Health, Inc. (OMDA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.26 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- Omada Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 1.26M shares, a 90.01% decline year-over-year.
- Omada Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 13.84M shares, a 73.36% decline year-over-year.
- Omada Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 12.65M shares.
- Omada Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 51.96M shares.
- Omada Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 11.80M shares, a 76.76% decline from fiscal 2024.
- Omada Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 50.78M shares, a 1.71% increase from fiscal 2023.
- Omada Health, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 49.92M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.26M shares 10-Q · filed 2026-08-07 | 1.17M shares 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | 13.84M shares 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | 11.80M shares 10-K · filed 2026-03-06 | |||
| 2025-09-30 | 12.14M shares 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 12.65M shares 10-Q · filed 2026-08-07 | 12.65M shares 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | 51.96M shares 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | 50.78M shares 10-K · filed 2026-03-06 | |||
| 2024-09-30 | 51.05M shares 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | 50.78M shares 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | 49.92M shares 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |